Boston Scientific Corporation $703 Million Infringement Appeal Denied

October 7, 2008 |

1 min read

Boston Scientific Corp. declined to comment Monday on news that the U.S. Supreme Court declined to hear the company’s appeal over a $703 million patent infringement award against the company.

Legal

MORE ON THIS TOPIC

Digital compass. Business strategic explorer, Vision crisis, Mission path, Agency creative, Digital strategy, Market decision, Achievement strategy, Financial stock, Company vision concepts

Policy

FDA Policy Tracker 2026: One-Trial Drug Applications, Guidelines for Personalized Therapies

February 27, 2026

·

7 min read

·

Heather McKenzie

President Donald Trump calls out the first patient to access his TrumpRx drug platform during his State of the Union address at the U.S. Capitol on Tuesday, February 24, 2026.

Drug pricing

Trump Calls on Congress To Codify Most Favored Nation Drug Pricing in SOTU

February 25, 2026

·

2 min read

·

Annalee Armstrong

The white plane flies against the blue sky, leaving a white trail. Vector illustration

Vaccines

Postponed ACIP Meeting Rescheduled for Mid-March

February 25, 2026

·

3 min read

·

Tristan Manalac

Illustration of man walking in the beach between two blue seas, surreal abstract path concept

Rare disease

FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases

February 23, 2026

·

3 min read

·

Nick Paul Taylor